Engrail Therapeutics Closes Oversubscribed $157M Series B Financing Round to Advance the Development of Transformational Therapies

by Ysios Capital

The round was co-led by new investors F-Prime Capital, Forbion, and Norwest Venture Partners, with participation from RiverVest Venture Partners, Red Tree Venture Capital, funds managed by abrdn Inc.,...

Read more

Axon reinforces its leadership in the Life Sciences sector with 2 new investments: Forbion & Sofinnova Partners

by Axon Partners Group

Aurora has already committed to five Life Sciences funds, with current exposure in the portfolio over 45%. The new investments are a strong fit for the overall fund strategy as they are with top-perfo...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Miura Partners' Impact Fund acquires a 2...

by Miura Partners

Bianna, a leading multinational in engineering, design, manufacturing,...

Photos Stream